Lucknow-based health-tech startup Dectrocel is revolutionizing diagnostics in India by deploying AI-driven solutions that analyze chest X-rays and CT scans with 98% accuracy. Founded by siblings Ankit and Saumya Shukla, the company is bridging healthcare gaps in Tier 2 and Tier 3 cities, ensuring specialist-level diagnostics reach underserved communities.
India’s fragmented diagnostic ecosystem has long left millions without timely, accurate medical insights. Dectrocel, a Lucknow-based startup, is tackling this challenge head-on with its flagship AI platform, DecXpert, which delivers precision diagnostics across respiratory diseases like tuberculosis, pneumonia, and lung cancer.
Key Highlights:
-
AI Accuracy: DecXpert achieves 98% diagnostic accuracy in chest X-rays and CT scans.
-
Accessibility: Expands specialist-level diagnostics to Tier 2 and Tier 3 healthcare facilities, reducing reliance on urban centers.
-
Founders’ Vision: Co-founded by siblings Ankit and Saumya Shukla, inspired by their parents’ medical college experiences.
-
Funding Boost: Recently raised ₹4 crore from IAN BioAngels, PadUp Ventures, and Vinners to scale operations and expand globally.
-
Future Plans: Developing AI modules for CT, MRI, PET-CT, and HPB diagnostics, aiming to cover broader medical needs.
By combining cutting-edge AI with a mission-driven approach, Dectrocel is not only addressing India’s diagnostic challenges but also setting the stage for global healthcare innovation.
Sources: YourStory, The Entrepreneur Story